Target Price | $158.67 |
Price | $96.83 |
Potential | 63.86% |
Number of Estimates | 30 |
30 Analysts have issued a price target Arm 2026 . The average Arm target price is $158.67. This is 63.86% higher than the current stock price. The highest price target is $225.00 132.37% , the lowest is $80.00 17.38% . | |
A rating was issued by 41 analysts: 23 Analysts recommend Arm to buy, 14 to hold and 4 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Arm stock has an average upside potential 2026 of 63.86% . Most analysts recommend the Arm stock at Purchase. |
34 Analysts have issued a sales forecast Arm 2025 . The average Arm sales estimate is $4.0b . This is 8.34% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $4.1b 10.17% , the lowest is $4.0b 7.99% .
This results in the following potential growth metrics:
2024 | $3.2b | 20.68% |
---|---|---|
2025 | $4.0b | 23.79% |
2026 | $4.9b | 22.90% |
2027 | $6.0b | 22.00% |
2028 | $6.8b | 13.46% |
2029 | $7.9b | 16.67% |
16 Analysts have issued an Arm EBITDA forecast 2025. The average Arm EBITDA estimate is $2.0b . This is 227.83% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $2.1b 235.07% , the lowest is $1.8b 197.88% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $261m | 69.23% |
---|---|---|
2025 | $2.0b | 669.97% |
2026 | $2.6b | 27.04% |
2027 | $3.4b | 32.96% |
2028 | $4.2b | 22.52% |
2029 | $5.8b | 38.53% |
2024 | 8.07% | 74.50% |
---|---|---|
2025 | 50.21% | 521.95% |
2026 | 51.90% | 3.37% |
2027 | 56.56% | 8.98% |
2028 | 61.08% | 7.99% |
2029 | 72.53% | 18.75% |
20 Arm Analysts have issued a net profit forecast 2025. The average Arm net profit estimate is $941m . This is 17.43% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $1.0b 27.63% , the lowest is $822m 2.63% .
This results in the following potential growth metrics and future Net Margins:
2024 | $306m | 43.14% |
---|---|---|
2025 | $941m | 207.76% |
2026 | $1.4b | 44.77% |
2027 | $1.9b | 40.16% |
2028 | $2.6b | 34.45% |
2029 | $3.2b | 24.44% |
2024 | 9.45% | 52.88% |
---|---|---|
2025 | 23.51% | 148.67% |
2026 | 27.69% | 17.78% |
2027 | 31.81% | 14.88% |
2028 | 37.70% | 18.52% |
2029 | 40.21% | 6.66% |
20 Analysts have issued a Arm forecast for earnings per share. The average Arm EPS is $0.89 . This is 17.11% higher than earnings per share in the financial year 2024. The highest EPS forecast is $0.97 27.63% , the lowest is $0.78 2.63% .
This results in the following potential growth metrics and future valuations:
2024 | $0.29 | 43.14% |
---|---|---|
2025 | $0.89 | 206.90% |
2026 | $1.29 | 44.94% |
2027 | $1.81 | 40.31% |
2028 | $2.44 | 34.81% |
2029 | $3.03 | 24.18% |
Current | 132.91 | 91.77% |
---|---|---|
2025 | 112.86 | 15.09% |
2026 | 77.96 | 30.92% |
2027 | 55.62 | 28.66% |
2028 | 41.37 | 25.62% |
2029 | 33.24 | 19.65% |
Based on analysts' sales estimates for 2025, the Arm stock is valued at an EV/Sales of 25.93 and an P/S ratio of 26.53 .
This results in the following potential growth metrics and future valuations:
Current | 28.09 | 35.38% |
---|---|---|
2025 | 25.93 | 7.69% |
2026 | 21.10 | 18.63% |
2027 | 17.29 | 18.03% |
2028 | 15.24 | 11.86% |
2029 | 13.06 | 14.29% |
Current | 28.74 | 34.98% |
---|---|---|
2025 | 26.53 | 7.70% |
2026 | 21.59 | 18.63% |
2027 | 17.69 | 18.03% |
2028 | 15.59 | 11.86% |
2029 | 13.37 | 14.29% |
Analyst | Rating | Action | Date |
---|---|---|---|
B of A Securities |
Buy
➜
Buy
|
Unchanged | Apr 16 2025 |
Morgan Stanley |
Overweight
➜
Overweight
|
Unchanged | Mar 28 2025 |
Loop Capital |
Buy
➜
Buy
|
Unchanged | Feb 10 2025 |
Benchmark |
Hold
➜
Hold
|
Unchanged | Feb 07 2025 |
Goldman Sachs |
Buy
➜
Buy
|
Unchanged | Feb 06 2025 |
Jefferies |
Buy
➜
Buy
|
Unchanged | Feb 06 2025 |
Benchmark |
Hold
➜
Hold
|
Unchanged | Feb 06 2025 |
Analyst Rating | Date |
---|---|
Unchanged
B of A Securities:
Buy
➜
Buy
|
Apr 16 2025 |
Unchanged
Morgan Stanley:
Overweight
➜
Overweight
|
Mar 28 2025 |
Unchanged
Loop Capital:
Buy
➜
Buy
|
Feb 10 2025 |
Unchanged
Benchmark:
Hold
➜
Hold
|
Feb 07 2025 |
Unchanged
Goldman Sachs:
Buy
➜
Buy
|
Feb 06 2025 |
Unchanged
Jefferies:
Buy
➜
Buy
|
Feb 06 2025 |
Unchanged
Benchmark:
Hold
➜
Hold
|
Feb 06 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.